Recruiting CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors NCT05733000 Conditions Adenocarcinoma, Adenocarcinoma of Lung, Adnexal Diseases, +67 more Locations Northwestern University — Chicago, Illinois, United States View Trial Details
